nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—Walking disability—Vincristine—muscle cancer	0.0977	0.216	CcSEcCtD
Perhexiline—CYP2B6—Doxorubicin—muscle cancer	0.0688	0.366	CbGbCtD
Perhexiline—CPT1A—renal system—muscle cancer	0.0347	0.0964	CbGeAlD
Perhexiline—CYP3A4—Vincristine—muscle cancer	0.0338	0.18	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—muscle cancer	0.0332	0.177	CbGbCtD
Perhexiline—CPT2—renal system—muscle cancer	0.0329	0.0915	CbGeAlD
Perhexiline—CYP3A4—Etoposide—muscle cancer	0.031	0.165	CbGbCtD
Perhexiline—CPT2—cardiac atrium—muscle cancer	0.0295	0.0819	CbGeAlD
Perhexiline—CPT1A—tendon—muscle cancer	0.0271	0.0752	CbGeAlD
Perhexiline—CPT2—tendon—muscle cancer	0.0257	0.0714	CbGeAlD
Perhexiline—CPT1A—vagina—muscle cancer	0.0251	0.0698	CbGeAlD
Perhexiline—CPT2—bone marrow—muscle cancer	0.0249	0.0692	CbGeAlD
Perhexiline—CPT2—vagina—muscle cancer	0.0239	0.0663	CbGeAlD
Perhexiline—CPT1A—head—muscle cancer	0.0232	0.0645	CbGeAlD
Perhexiline—CPT1A—testis—muscle cancer	0.0224	0.0623	CbGeAlD
Perhexiline—CPT2—head—muscle cancer	0.022	0.0612	CbGeAlD
Perhexiline—CPT2—testis—muscle cancer	0.0213	0.0591	CbGeAlD
Perhexiline—CYP3A4—Doxorubicin—muscle cancer	0.0211	0.112	CbGbCtD
Perhexiline—Cachexia—Doxorubicin—muscle cancer	0.0166	0.0366	CcSEcCtD
Perhexiline—Optic neuritis—Etoposide—muscle cancer	0.0148	0.0328	CcSEcCtD
Perhexiline—Polyneuropathy—Doxorubicin—muscle cancer	0.0145	0.0321	CcSEcCtD
Perhexiline—Gait disturbance—Vincristine—muscle cancer	0.0115	0.0255	CcSEcCtD
Perhexiline—CYP2B6—renal system—muscle cancer	0.00857	0.0238	CbGeAlD
Perhexiline—Optic neuritis—Doxorubicin—muscle cancer	0.00769	0.017	CcSEcCtD
Perhexiline—Ataxia—Vincristine—muscle cancer	0.00769	0.017	CcSEcCtD
Perhexiline—Muscular weakness—Vincristine—muscle cancer	0.00721	0.016	CcSEcCtD
Perhexiline—CYP3A4—renal system—muscle cancer	0.00647	0.018	CbGeAlD
Perhexiline—Weight decreased—Vincristine—muscle cancer	0.00639	0.0141	CcSEcCtD
Perhexiline—CYP2D6—renal system—muscle cancer	0.00637	0.0177	CbGeAlD
Perhexiline—Hepatitis—Dactinomycin—muscle cancer	0.00633	0.014	CcSEcCtD
Perhexiline—CYP2B6—vagina—muscle cancer	0.00621	0.0172	CbGeAlD
Perhexiline—Neuropathy peripheral—Vincristine—muscle cancer	0.00617	0.0137	CcSEcCtD
Perhexiline—Sweating—Vincristine—muscle cancer	0.00604	0.0134	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—muscle cancer	0.00587	0.013	CcSEcCtD
Perhexiline—CYP2B6—head—muscle cancer	0.00574	0.0159	CbGeAlD
Perhexiline—Liver injury—Doxorubicin—muscle cancer	0.00562	0.0124	CcSEcCtD
Perhexiline—CYP2B6—testis—muscle cancer	0.00554	0.0154	CbGeAlD
Perhexiline—Neuropathy peripheral—Etoposide—muscle cancer	0.005	0.0111	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—muscle cancer	0.00485	0.0107	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—muscle cancer	0.00473	0.0105	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—muscle cancer	0.00429	0.00948	CcSEcCtD
Perhexiline—Convulsion—Vincristine—muscle cancer	0.00426	0.00944	CcSEcCtD
Perhexiline—CYP2D6—head—muscle cancer	0.00426	0.0118	CbGeAlD
Perhexiline—Flushing—Etoposide—muscle cancer	0.00425	0.00941	CcSEcCtD
Perhexiline—CYP2D6—testis—muscle cancer	0.00412	0.0114	CbGeAlD
Perhexiline—Decreased appetite—Dactinomycin—muscle cancer	0.00391	0.00865	CcSEcCtD
Perhexiline—Hyperhidrosis—Vincristine—muscle cancer	0.00388	0.00859	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—muscle cancer	0.00388	0.00858	CcSEcCtD
Perhexiline—Anorexia—Vincristine—muscle cancer	0.00383	0.00847	CcSEcCtD
Perhexiline—Ataxia—Methotrexate—muscle cancer	0.00373	0.00825	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00368	0.00814	CcSEcCtD
Perhexiline—Insomnia—Vincristine—muscle cancer	0.00363	0.00804	CcSEcCtD
Perhexiline—Paraesthesia—Vincristine—muscle cancer	0.00361	0.00798	CcSEcCtD
Perhexiline—Abdominal pain—Dactinomycin—muscle cancer	0.00355	0.00786	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—muscle cancer	0.00352	0.00779	CcSEcCtD
Perhexiline—Loss of consciousness—Etoposide—muscle cancer	0.0035	0.00775	CcSEcCtD
Perhexiline—Decreased appetite—Vincristine—muscle cancer	0.00349	0.00773	CcSEcCtD
Perhexiline—Fatigue—Vincristine—muscle cancer	0.00346	0.00766	CcSEcCtD
Perhexiline—Convulsion—Etoposide—muscle cancer	0.00345	0.00764	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—muscle cancer	0.00343	0.0076	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vincristine—muscle cancer	0.00328	0.00727	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—muscle cancer	0.00323	0.00714	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—muscle cancer	0.00323	0.00714	CcSEcCtD
Perhexiline—Abdominal pain—Vincristine—muscle cancer	0.00318	0.00703	CcSEcCtD
Perhexiline—Hyperhidrosis—Etoposide—muscle cancer	0.00315	0.00696	CcSEcCtD
Perhexiline—Anorexia—Etoposide—muscle cancer	0.0031	0.00686	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—muscle cancer	0.00303	0.0067	CcSEcCtD
Perhexiline—Sweating—Methotrexate—muscle cancer	0.00293	0.00648	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—muscle cancer	0.00292	0.00647	CcSEcCtD
Perhexiline—Asthenia—Vincristine—muscle cancer	0.00288	0.00638	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—muscle cancer	0.00286	0.00633	CcSEcCtD
Perhexiline—Rash—Dactinomycin—muscle cancer	0.00283	0.00627	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—muscle cancer	0.00283	0.00626	CcSEcCtD
Perhexiline—Fatigue—Etoposide—muscle cancer	0.00281	0.00621	CcSEcCtD
Perhexiline—Hepatitis—Methotrexate—muscle cancer	0.00274	0.00607	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—muscle cancer	0.00269	0.00594	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—muscle cancer	0.00267	0.00591	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—muscle cancer	0.00266	0.00589	CcSEcCtD
Perhexiline—Dizziness—Vincristine—muscle cancer	0.00266	0.00588	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00259	0.00574	CcSEcCtD
Perhexiline—Urticaria—Etoposide—muscle cancer	0.00259	0.00572	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—muscle cancer	0.00257	0.00569	CcSEcCtD
Perhexiline—Vomiting—Vincristine—muscle cancer	0.00255	0.00565	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—muscle cancer	0.00254	0.00561	CcSEcCtD
Perhexiline—Rash—Vincristine—muscle cancer	0.00253	0.0056	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—muscle cancer	0.00253	0.0056	CcSEcCtD
Perhexiline—Headache—Vincristine—muscle cancer	0.00252	0.00557	CcSEcCtD
Perhexiline—Nausea—Vincristine—muscle cancer	0.00239	0.00528	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—muscle cancer	0.00238	0.00526	CcSEcCtD
Perhexiline—Asthenia—Etoposide—muscle cancer	0.00233	0.00517	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—muscle cancer	0.0022	0.00488	CcSEcCtD
Perhexiline—Dizziness—Etoposide—muscle cancer	0.00215	0.00476	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—muscle cancer	0.00207	0.00458	CcSEcCtD
Perhexiline—Vomiting—Etoposide—muscle cancer	0.00207	0.00458	CcSEcCtD
Perhexiline—Rash—Etoposide—muscle cancer	0.00205	0.00454	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—muscle cancer	0.00205	0.00454	CcSEcCtD
Perhexiline—Headache—Etoposide—muscle cancer	0.00204	0.00451	CcSEcCtD
Perhexiline—Tension—Doxorubicin—muscle cancer	0.00203	0.00449	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—muscle cancer	0.00201	0.00444	CcSEcCtD
Perhexiline—Nausea—Etoposide—muscle cancer	0.00193	0.00428	CcSEcCtD
Perhexiline—Hyperhidrosis—Methotrexate—muscle cancer	0.00188	0.00417	CcSEcCtD
Perhexiline—Anorexia—Methotrexate—muscle cancer	0.00186	0.00411	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—muscle cancer	0.00185	0.0041	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—muscle cancer	0.00182	0.00402	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—muscle cancer	0.00179	0.00396	CcSEcCtD
Perhexiline—Insomnia—Methotrexate—muscle cancer	0.00176	0.0039	CcSEcCtD
Perhexiline—Paraesthesia—Methotrexate—muscle cancer	0.00175	0.00387	CcSEcCtD
Perhexiline—Decreased appetite—Methotrexate—muscle cancer	0.00169	0.00375	CcSEcCtD
Perhexiline—Fatigue—Methotrexate—muscle cancer	0.00168	0.00372	CcSEcCtD
Perhexiline—Shock—Doxorubicin—muscle cancer	0.00166	0.00367	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—muscle cancer	0.00163	0.00361	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—muscle cancer	0.00161	0.00356	CcSEcCtD
Perhexiline—Gastrointestinal pain—Methotrexate—muscle cancer	0.00159	0.00353	CcSEcCtD
Perhexiline—Urticaria—Methotrexate—muscle cancer	0.00155	0.00343	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—muscle cancer	0.00154	0.00341	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—muscle cancer	0.00153	0.00338	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—muscle cancer	0.00152	0.00335	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—muscle cancer	0.00147	0.00325	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—muscle cancer	0.00146	0.00322	CcSEcCtD
Perhexiline—Asthenia—Methotrexate—muscle cancer	0.0014	0.00309	CcSEcCtD
Perhexiline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00138	0.00305	CcSEcCtD
Perhexiline—Urticaria—Doxorubicin—muscle cancer	0.00134	0.00297	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—muscle cancer	0.00133	0.00295	CcSEcCtD
Perhexiline—Dizziness—Methotrexate—muscle cancer	0.00129	0.00285	CcSEcCtD
Perhexiline—Vomiting—Methotrexate—muscle cancer	0.00124	0.00274	CcSEcCtD
Perhexiline—Rash—Methotrexate—muscle cancer	0.00123	0.00272	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—muscle cancer	0.00123	0.00272	CcSEcCtD
Perhexiline—Headache—Methotrexate—muscle cancer	0.00122	0.0027	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—muscle cancer	0.00121	0.00268	CcSEcCtD
Perhexiline—Nausea—Methotrexate—muscle cancer	0.00116	0.00256	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—muscle cancer	0.00112	0.00247	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—muscle cancer	0.00107	0.00237	CcSEcCtD
Perhexiline—Rash—Doxorubicin—muscle cancer	0.00106	0.00235	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—muscle cancer	0.00106	0.00235	CcSEcCtD
Perhexiline—Headache—Doxorubicin—muscle cancer	0.00106	0.00234	CcSEcCtD
Perhexiline—Nausea—Doxorubicin—muscle cancer	0.001	0.00222	CcSEcCtD
